Related Experiment Videos
Methamphetamine-induced behavioural effects and brain concentrations of methamphetamine and its metabolite
Abstract:
(+)-Methamphetamine (MA) produced dose-related behavioural changes in mice. There was a correlation between the type of behavioural response and the peak brain MA concentration after the i.p. administration of each of the following doses of (+)-MA: 0.64 mg/kg (decreased quiescence--0.738 microgram/g MA), 2.5 mg/kg (increased locomotor activity--3.148 microgram/g MA) and 10.0 mg/kg (stereotyped behaviour--12.608 microgram/g MA). During the 90-min experimental period, there was no positive correlation between the magnitude of each type of drug-induced behaviour and the brain MA concentration. For 10.0 mg/kg (+)-MA, there was a negative correlation between the drug-induced stereotyped behaviour and the brain MA concentration. The apparent disappearance half-life of MA from brain was dependent on the dose of (+)-MA: 0.64 mg/kg (t1/2 56.6 min), 2.5 mg/kg (t1/2 66.6 min), 10.0 mg/kg (42.2 min). For the three (+)-MA doses, the metabolite amphetamine (A) also was present in the brain and the A/MA + A brain concentration ratio was 0.11--0.14. This metabolite appeared to have only a small involvement in the MA-induced behavioural effects.
Insights
(+)-Methamphetamine (MA) causes dose-dependent behavioral changes in mice, with peak brain MA concentrations correlating to specific responses. Amphetamine, a metabolite, showed minimal involvement in these MA-induced effects.
Area of Science:
- Neuroscience
- Pharmacology
- Behavioral Science
Background:
- (+)-Methamphetamine (MA) is a psychostimulant with known behavioral effects.
- Understanding the relationship between drug concentration, metabolism, and behavior is crucial in pharmacology.
Purpose of the Study:
- To investigate the dose-related behavioral effects of (+)-Methamphetamine in mice.
- To correlate brain MA concentrations with specific behavioral responses and examine the role of amphetamine metabolite.
Main Methods:
- Administration of varying doses of (+)-MA (0.64, 2.5, 10.0 mg/kg) to mice.
- Measurement of peak brain (+)-Methamphetamine concentrations.
- Observation and quantification of behavioral changes (quiescence, locomotor activity, stereotypy).
- Analysis of amphetamine metabolite levels in the brain.
Main Results:
- Dose-dependent behavioral changes observed: decreased quiescence, increased locomotor activity, and stereotyped behavior.
- Peak brain MA concentrations correlated with the *type* of behavioral response, but not the *magnitude* during the 90-min period.
- Negative correlation between stereotyped behavior and brain MA concentration at the highest dose.
- Apparent brain MA half-life varied with dose (56.6-66.6 min, except 42.2 min for 10.0 mg/kg).
- Amphetamine metabolite was present (0.11-0.14 ratio) but showed minimal involvement in MA-induced behaviors.
Conclusions:
- (+)-Methamphetamine induces distinct behavioral effects in mice that are related to dose and peak brain concentrations.
- The magnitude of behavioral effects did not consistently correlate with brain MA levels over time.
- Amphetamine appears to play a minor role in the observed behavioral pharmacology of (+)-Methamphetamine.